Skip to content

Pharmaceutical Standardization Of Yashada Bhasma and their clinical efficacy in Type-II Diabetes Mellitus.

Pharmaceutical Standardization Of Yashada Bhasma Prepared By Two Different Methods And Their Comparitive Efficacy On Madhumeha (Type-II Diabetes Mellitus). - T2DM

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006684
Enrollment
100
Registered
2016-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from the signs and symptoms of type 2 DM

Interventions

Intervention1: One group of patients will be administered with capsules of Parada marita Yashada Bhasma (125 mg) with Guduchi Ghana (375 mg): 500 mg sized capsules will be administered with honey twic

Sponsors

IPGT AND RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both the sexes having Age between 30 years to 60 years Patients having classical symptomatology of Madhumeha (Prabhutamutrata, Avilamutrata etc) Symptoms of Diabetes (Polyuria, Polydypsia, Polyphagia and Weight loss) Patients having Blood sugar Fasting Blood Sugar ? 126 mg/dl Post Prandial Blood Sugar ? 200 mg/dl

Exclusion criteria

Exclusion criteria: 1. Age below 30 and above 65 years. 2. Malignant and accelerated Hypertension. 3. Patients having chronic complications of Diabetes Mellitus a. Microvascular: Retinopathy, Neuropathy, & Nephropathy. b. Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease. c. Other chronic debilitating diseases like STD etc. 4. Pregnant women 5. Lactating mothers 6. Secondary Diabetes mellitus 7. Patients of any other severe illness

Design outcomes

Primary

MeasureTime frame
Yashada bhasma prepared in the presence of Parada administered with Guduchi Ghana will be effective against the Yashada bhasma prepared using herbal media administered with Guduchi Ghana in the management of Type-2 DM.Timepoint: two months

Secondary

MeasureTime frame
Quality of life will be improvedTimepoint: 1 month

Countries

India

Contacts

Public ContactB J PATGIRI

IPGT and RA GUJARAT AYURVED UNIVERSITY

patgiri124@gmail.com9426947438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026